7 Regulatory Milestones Accelerating Therapeutic Cancer Vaccine Approvals in 2026
The FDA's Oncology Center of Excellence published its 2025 Annual Report in February 2026 confirming that therapeutic cancer vaccines now represent the single fastest-growing category in its accelerated approval program — with five products receiving accelerated approvals in 2025 alone — and announcing a new Oncology Vaccine Task Force that will establish unified evidentiary...
0 Σχόλια 0 Μοιράστηκε 340 Views 0 Προεπισκόπηση